Consistent with previously reported association of single nucleotide polymorphisms (SNPs) in the serine-threonine kinase STK33 gene with hypertension in Europeans (37), our investigation revealed several STK33 inhibitors as effective drugs targeting the attenuated LPS response associated with hypertension (Figure 4B). The gene discussed is STK33; the disease is hypertensive disorder.